Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Vaxiion Therapeutics (United States) | Researchclopedia

Back to institutions

Vaxiion Therapeutics (United States)

San Diego, Californiacompany

20

Works

823

Citations

16

h-index

Top Research Topics

Cancer Research and Treatments Immunotherapy and Immune Responses Cancer Immunotherapy and Biomarkers

Top Researchers

Michael Newman Royal Devon & Exeter NHS Foundation Trust

243 works8,845 citationsh-index: 45

Recent Research

615 Phase 1 study of intratumoral VAX014 with dose expansion in combination with pembrolizumab or nivolumab in patients with advanced solid tumors

Ryan Weight,Gerald S. Falchook,et al.

20250 citations

Bladder and Urothelial Cancer Treatments

Virus-based gene therapy research

Nanoplatforms for cancer theranostics

interferon and immune responses

Bacteriophages and microbial interactions

Radiopharmaceutical Chemistry and Applications

Lymphoma Diagnosis and Treatment

Lung Cancer Treatments and Mutations

Prostate Cancer Treatment and Research

Shingo Tsuji Vaxiion Therapeutics (United States)

329 works8,414 citationsh-index: 44

Roger A. Sabbadini San Diego State University

117 works5,457 citationsh-index: 44

Marco Giacalone Istituto Nazionale di Fisica Nucleare, Sezione di Bologna

227 works1,644 citationsh-index: 20

Kathleen L. McGuire San Diego State University

97 works1,402 citationsh-index: 23

Bryan Hancock University of California, San Diego

39 works1,078 citationsh-index: 12

885 Intratumoral administration of VAX014 induces tertiary lymphoid structure formation

Amanda M. Parikh,Katherine A. Reil,et al.

20250 citations

VAX014 Activates Tumor-Intrinsic STING and RIG-I to Promote the Development of Antitumor Immunity

Kinsey L. Nelson,Katherine A. Reil,et al.

20252 citations

988 VAX014 activates multiple STING-mediated innate immune pathways to facilitate <i>in situ</i> immunization

Kinsey L. Nelson,Gregory W Ho,et al.

20240 citations

667 Phase 1 study of intratumoral administration of VAX014 in subjects with advanced solid tumors

Elizabeth I. Buchbinder,Ryan Weight,et al.

20240 citations

The promise, progress, and challenges of in situ immunization agents in cancer immunotherapy

Matthew J. Giacalone

20241 citations